Gastroenteritis in Pediatric Population of Qatar

Recruiting

• Conditions: Gastroenteritis

• Registration Number: NCT03046342
• Lead Sponsor: Hamad Medical Corporation

Brief Summary

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Detailed Description

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Study Timeline

• Study Start: 2015-03-10
• Study First Submitted: 2017-01-31
• Study First Submitted QC: 2017-02-05
• Study First Posted: 2017-02-08
• Status Verified: 2023-02
• Last Update Submitted: 2024-03-21
• Last Update Posted: 2024-03-22
• Primary Completion: 2024-09-10
• Study Completion: 2024-12-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

• All acute gastroenteritis patients between 3 months to 14 years presenting to PEC centers with acute diarrhea+/- vomiting with or without fever

Exclusion Criteria

1. Cases of vomiting +/- fever only without diarrhea
2. Suspicion of surgical abdomen
3. Bile stained vomitus
4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion as disaccharides deficiency
5. Cases of Inflammatory bowel disease
6. Antibiotic associated diarrhea
7. Patients with immune deficiency
8. Patients with chronic diarrhea (>2 weeks of diarrhea)
9. Patients receiving long term medication for any disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
sources of viral, bacterial and parasitic GE in the country	4 years	Prevalence of viral, bacterial and parasitic GE in children \< 14 years of age in Qatar will be identified by molecular method sample processing

Secondary Outcome Measures

Name	Time	Method
comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine	4 years	comparing the prevalence of viral GE in vaccinated children in Qatar (against rotavirus) and the other countries which implemented rotavirus vaccine by detection of source of GE in vaccinated children by molecular method.
seasonal variation of GE in qatar determination	4 years	seasonal variation of GE in qatar being determined by number of cases reported during each season

Trial Locations

Locations (1)

Hamad medical corporation; 🇶🇦 Doha, Qatar